Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Nanobody
| Nanobody |
| Autore | Rothbauer Ulrich |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (300 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
Aids
anti-cytokine therapy antibody autoimmune disease Bacillus anthracis Beta galactosidase bi-specific VHH biodefense blood-brain barrier brain imaging BRET c-Met C. elegans camelid Cancer cellular models chromobodies co-crystallisation competition studies compound screening delivery development drosophila epitope mapping Fc-domain fluorescent formatting genetic fusion GFP GTPase RHO half-life hemagglutinin hepatocyte growth factor receptor HGFR HIV hydrogen exchange-mass spectrometry Imaging immunoassay Immunotherapy influenza influenza B virus intrabody intracellular antibody intraoperative imaging ischemia live-cell imaging llama Llama Antibodies MagPlex MCAO Met molecular imaging molecular therapy n/a nanobodies nanobody Nanobody NanobodyTM neurodegenerative diseases nuclear imaging P-type ATPase pepscan phage display photosensitizer RAS sensor single domain antibodies single domain antibody Single Domain Antibody single-domain antibodies single-domain antibody single-domain antibody fragments stroke targeted fluorescence imaging targeted photodynamic therapy TNF toxin vaccine VHH virus Western equine encephalitis virus yeast display zebrafish Zinc-transport Zinc-transporting P-ATPase ZntA |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557147503321 |
Rothbauer Ulrich
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Treatment Strategies for Glioblastoma
| Novel Treatment Strategies for Glioblastoma |
| Autore | Stylli Stanley |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (268 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
angiopoietin (Ang)
anti-angiogenesis anticancer brain cancer brain tumor cancer stem cell cancer stem cell niche cancer stem cells cell cycle chimeric antigen receptor (CAR) T cells CK2 CRISPR/Cas9 CX-4945 de novo purine synthesis differentiation drug repurposing drug targets drug-inducible gene expression endothelial nitric oxide synthase (eNOS) GBM gene therapy glioblastoma glioblastoma (GB) glioblastoma multiforme glioma immune checkpoint inhibitors immunotherapy invadopodia invasion ion channels Mardepodect metabolic reprogramming metabolic treatment migration n/a nanomedicine nerve/glial antigen 2 new trial design newly diagnosed glioblastoma NG2 novel therapy one-carbon metabolism organoids P-bi-TAT P-m-TAT PEG personalized treatment pluripotent stem cells proliferation prolyl-oligopeptidase (POP) radiotherapy RAS recurrent glioblastoma Regorafenib renin-angiotensin system SRGAP2 stem cell targeted therapy temozolomide tetrac thyrointegrin αvβ3 TP53 transforming growth factor-β (TGF-β) triazole tetrac tumor antigens tumor microenvironment vaccine vascular endothelial growth factor (VEGF) viral vectors |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557363703321 |
|
Stylli Stanley
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Oncolytic Virus Immunotherapy
| Oncolytic Virus Immunotherapy |
| Autore | Marchini Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
adenovirus
adoptive T cell therapy antigen-agnostic vaccination antitumor immune response arming biomarkers cancer cancer immune therapy cancer immunotherapy cancer therapy CAR T cell checkpoint inhibitor checkpoint inhibitors class I HLA clinical trials colorectal cancer combination therapy combinatory therapy CTLA-4 delivery DNA methyltransferase inhibitor (DNMTi) epigenetic silencing genetic modification glioblastoma HER2 herpes simplex virus HSV-1 immune checkpoint blockade immune checkpoint inhibitor immunoediting immunogenic cell death immunostimulatory immunosurveillance immunotherapy measles virus melanoma multi-stage n/a NDV newcastle disease virus oncogenic signaling oncolytic oncolytic adenovirus oncolytic virus oncolytic viruses pancreatic cancer pancreatic ductal adenocarcinoma parvovirus PD-1 PD-L1 personalized oncolyticvirotherapy RAS reovirus retargeted virus small molecule targeting tropism retargeting tumor tumor microenvironment type I interferon vaccination vector engineering vesicular stomatitis virus viral mimicry virotherapy αvβ6 integrin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566462203321 |
|
Marchini Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||